ATE500826T1 - Verwendung von azabicyclohexan-derivaten - Google Patents

Verwendung von azabicyclohexan-derivaten

Info

Publication number
ATE500826T1
ATE500826T1 AT06777058T AT06777058T ATE500826T1 AT E500826 T1 ATE500826 T1 AT E500826T1 AT 06777058 T AT06777058 T AT 06777058T AT 06777058 T AT06777058 T AT 06777058T AT E500826 T1 ATE500826 T1 AT E500826T1
Authority
AT
Austria
Prior art keywords
disorder
nervosa
hyperchondriasis
sydeham
paraphilia
Prior art date
Application number
AT06777058T
Other languages
English (en)
Inventor
Dieter Hamprecht
Christian Heidbreder
Sergio Melotto
Fabrizio Micheli
Tadataka Yamada
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE500826T1 publication Critical patent/ATE500826T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)
AT06777058T 2005-08-22 2006-08-21 Verwendung von azabicyclohexan-derivaten ATE500826T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0517193.9A GB0517193D0 (en) 2005-08-22 2005-08-22 Novel use
PCT/EP2006/008314 WO2007022980A1 (en) 2005-08-22 2006-08-21 Use of azabicyclo hexane derivatives

Publications (1)

Publication Number Publication Date
ATE500826T1 true ATE500826T1 (de) 2011-03-15

Family

ID=35098098

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06777058T ATE500826T1 (de) 2005-08-22 2006-08-21 Verwendung von azabicyclohexan-derivaten

Country Status (20)

Country Link
US (2) US20090036461A1 (de)
EP (1) EP1917013B1 (de)
JP (1) JP5166267B2 (de)
KR (1) KR101363090B1 (de)
CN (1) CN101291669B (de)
AT (1) ATE500826T1 (de)
AU (1) AU2006284077B2 (de)
BR (1) BRPI0614929A2 (de)
CA (1) CA2620090A1 (de)
CR (1) CR9807A (de)
DE (1) DE602006020589D1 (de)
EA (1) EA016084B1 (de)
ES (1) ES2361933T3 (de)
GB (1) GB0517193D0 (de)
IL (1) IL189435A0 (de)
MA (1) MA29774B1 (de)
MX (1) MX2008002564A (de)
NO (1) NO20081314L (de)
WO (1) WO2007022980A1 (de)
ZA (1) ZA200801352B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4960217B2 (ja) * 2004-02-23 2012-06-27 グラクソ グループ リミテッド ドーパミンｄ３受容体のモジュレーターとして有用なアザビシクロ（３．１．０）ヘキサン誘導体
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
GB0507602D0 (en) * 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
GB0507601D0 (en) * 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
GB0512099D0 (en) * 2005-06-14 2005-07-20 Glaxo Group Ltd Compounds
DE602006017543D1 (de) * 2005-06-14 2010-11-25 Glaxo Group Ltd Neue verbindungen
CA2659215C (en) 2005-07-27 2018-07-10 Dov Pharmaceutical, Inc. Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
GB0517187D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
EP1919908B1 (de) * 2005-08-22 2010-11-10 Glaxo Group Limited Triazolderivate als modulatoren von dopamin-d3-rezeptoren
GB0517191D0 (en) 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
GB0517175D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
GB0607899D0 (en) 2006-04-03 2006-05-31 Glaxo Group Ltd Process for preparing heterocyclic derivatives
JP5189076B2 (ja) * 2006-04-03 2013-04-24 グラクソ グループ リミテッド ドーパミンｄ３受容体のモジュレーターとしてのアザビシクロ［３．１．０］ヘキシル誘導体
EP2010518B1 (de) * 2006-04-03 2011-02-16 Glaxo Group Limited Azabicyclo[3.1.0]hexanderivate als modulatoren von dopamin-d3-rezeptoren
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds
US8138377B2 (en) 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
EP2167083B1 (de) * 2007-06-06 2015-10-28 Euthymics Bioscience, Inc. 1- heteroaryl-3-azabicyclo[3.1.0]hexane, verfahren zu ihrer herstellung und ihre verwendung als medikamente
EP2445887B1 (de) * 2009-06-26 2014-11-05 Panacea Biotec Limited Neuartige azabicyclohexane
WO2012033956A1 (en) * 2010-09-08 2012-03-15 Mithridion, Inc. Cognition enhancing compounds and compositions, methods of making, and methods of treating
US9314600B2 (en) 2012-04-15 2016-04-19 Bioconnect Systems, Inc. Delivery system for implantable flow connector
US11447484B2 (en) 2018-01-26 2022-09-20 Shionogi & Co., Ltd. Cyclic compound having dopamine D3 receptor antagonistic effect

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI244481B (en) 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
US20020103198A1 (en) * 2000-12-04 2002-08-01 Fliri Anton F.J Acylamino cyclopropane derivatives
JP4960217B2 (ja) * 2004-02-23 2012-06-27 グラクソ グループ リミテッド ドーパミンｄ３受容体のモジュレーターとして有用なアザビシクロ（３．１．０）ヘキサン誘導体
SE526837C2 (sv) * 2004-02-24 2005-11-08 Kongsberg Automotive Asa Växelspakstransmission
WO2006058753A1 (en) * 2004-12-02 2006-06-08 Abbott Gmbh & Co. Kg Triazole compounds suitable for treating disorders that respond to modulaiont of the dopamine d3 receptor
GB0507602D0 (en) * 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
GB0507601D0 (en) 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
GB0507680D0 (en) * 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
DE602006017543D1 (de) * 2005-06-14 2010-11-25 Glaxo Group Ltd Neue verbindungen
GB0512099D0 (en) * 2005-06-14 2005-07-20 Glaxo Group Ltd Compounds
GB0517175D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
EP1919908B1 (de) * 2005-08-22 2010-11-10 Glaxo Group Limited Triazolderivate als modulatoren von dopamin-d3-rezeptoren
GB0517191D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
GB0517187D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
ES2434337T3 (es) * 2006-04-03 2013-12-16 Glaxo Group Limited Derivados de azabiciclo[3.1.0]hexilo como moduladores de los receptores D3 de la dopamina
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
IL189435A0 (en) 2008-08-07
MX2008002564A (es) 2008-03-18
WO2007022980A1 (en) 2007-03-01
JP5166267B2 (ja) 2013-03-21
US20120196910A1 (en) 2012-08-02
JP2009506989A (ja) 2009-02-19
EA016084B1 (ru) 2012-02-28
GB0517193D0 (en) 2005-09-28
MA29774B1 (fr) 2008-09-01
ES2361933T3 (es) 2011-06-24
CN101291669B (zh) 2012-09-26
ZA200801352B (en) 2009-01-28
US20090036461A1 (en) 2009-02-05
CA2620090A1 (en) 2007-03-01
KR101363090B1 (ko) 2014-02-13
CR9807A (es) 2008-07-29
EA200800655A1 (ru) 2008-08-29
AU2006284077B2 (en) 2012-05-17
CN101291669A (zh) 2008-10-22
AU2006284077A1 (en) 2007-03-01
NO20081314L (no) 2008-03-17
EP1917013A1 (de) 2008-05-07
KR20080040022A (ko) 2008-05-07
BRPI0614929A2 (pt) 2011-04-19
EP1917013B1 (de) 2011-03-09
DE602006020589D1 (de) 2011-04-21

Similar Documents

Publication Publication Date Title
ATE500826T1 (de) Verwendung von azabicyclohexan-derivaten
BRPI0413234A (pt) derivados de imidazola bicìclica contra flaviviridae
EP2546246A3 (de) Verbindungen und Verfahren zur Behandlung oder Vorbeugung von Flavivirus-Infektionen
EA201000050A1 (ru) Замещенные бициклолактамные соединения
EA200802213A1 (ru) Способы лечения заболеваний крови
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
HK1121440A1 (en) Biphenyl derivatives and their use in treating hepatitis c
EA200700099A1 (ru) Производные пиридина
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
GEP20094727B (en) Oxyindole derivatives as 5ht4 receptor agonists
WO2006034093A3 (en) 3- (2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors
ATE532789T1 (de) Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
ATE486071T1 (de) Azabicycloä3.1.0ühexan-derivate als modulatoren des dopamin-d3-rezeptors
DK1483251T3 (da) C3-cyano-epothilon-derivater
ATE542796T1 (de) N-sulfonylcarboximidamidverbindungen als apoptosepromotoren
DE60221425D1 (de) Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase-inhibitoren
DE602005007765D1 (de) Neue indol- oder benzimidazol-derivate
EA200800780A1 (ru) Производные пиримидина и их применение в качестве открывателей калиевых каналов kcnq
RS20050649A (en) Antibacterial indolone oxazolidinones,intermediates for their preparation and pharmaceutical compositions containing them
JO2999B1 (ar) مركب ثلاثي حلقي و استخدامه الدوائي
ATE465151T1 (de) 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties